Paper75502
The cytogenetic effect of bleomycin on human peripheral lymphocytes in vitro and in vivo.
Dresp J and 2 others. Mutat Res, 1978. Cited by 94 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The cytogenetic effect of bleomycin on human peripheral lymphocytes in vitro and in vivo. Papers, record 75502. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/75502
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The cytogenetic effect of bleomycin on human peripheral lymphocytes in vitro and in vivo.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bleomycin | Major topic |
| Chromosomes | Major topic |
| Lymphocytes | Major topic |
| Mutagens | Major topic |
| Cell Cycle | |
| Chromosome Aberrations | |
| Dose-Response Relationship, Drug | |
| Humans | |
| In Vitro Techniques |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,731,680 | A Review on the Antimutagenic and Anticancer Effects of Cysteamine. | Adv Pharmacol Pharm Sci | 2023 | https://conductscience.org/library/papers/37731680 | PubMed |
| 30,320,184 | Immunogenic effects of chemotherapy-induced tumor cell death. | Genes Dis | 2018 | https://conductscience.org/library/papers/30320184 | PubMed |
| 28,626,752 | Protective Effect of a Polyherbal Aqueous Extract Comprised of Nigella sativa (Seeds), Hemidesmus indicus (Roots), and Smilax glabra (Rhizome) on Bleomycin Induced Cytogenetic Damage in Human Lymphocytes. | Biomed Res Int | 2017 | https://conductscience.org/library/papers/28626752 | PubMed |
| 26,907,305 | Protective Effect of Onion Extract on Bleomycin-Induced Cytotoxicity and Genotoxicity in Human Lymphocytes. | Int J Environ Res Public Health | 2016 | https://conductscience.org/library/papers/26907305 | PubMed |
| 23,762,310 | Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells. | PLoS One | 2013 | https://conductscience.org/library/papers/23762310 | PubMed |
| 8,552,041 | Modulation of bleomycin-induced mitotic recombination in yeast by the aminothiols cysteamine and WR-1065. | Mol Gen Genet | 1995 | https://conductscience.org/library/papers/8552041 | PubMed |
| 7,235,999 | Cytogenetical tests on mammalian cells in vitro. | Arch Toxicol | 1980 | https://conductscience.org/library/papers/7235999 | PubMed |
| 6,885,046 | Induction of structural chromosome aberrations and sister chromatid exchanges in human lymphocytes in vitro by aristolochic acid. | Hum Genet | 1983 | https://conductscience.org/library/papers/6885046 | PubMed |
| 6,204,884 | The cytogenetic efficiency of the antitumor agents bleomycin and peplomycin is enhanced by the heart drug verapamil (isoptin). | Experientia | 1984 | https://conductscience.org/library/papers/6204884 | PubMed |
| 6,199,286 | Bleomycin-induced chromosomal aberrations and sister chromatid exchanges in Down lymphocyte cultures. | Hum Genet | 1984 | https://conductscience.org/library/papers/6199286 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/75502
GET https://conductscience.org/api/papers/v1/75502/authors